In non-diabetic pigs [7] and mice subjected to myocardial infarction [26], SGLT2 inhibition ameliorated adverse remodeling and led to normalization of glucose and fatty acid metabolism. This evidence concerns the gene SLC5A2 and myocardial infarction.